Hannah Linden | Breast Cancer Research ...

Dr. Hannah Linden, MD

Claim this profile

Fred Hutch/University of Washington Cancer Consortium

Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
8 drugs studied

Area of expertise

1Breast Cancer
Hannah Linden, MD has run 6 trials for Breast Cancer. Some of their research focus areas include:
ER positive
Stage IV
metastatic
2Breast Cancer
Hannah Linden, MD has run 2 trials for Breast cancer. Some of their research focus areas include:
ER positive
Stage IV
HER2 negative

Affiliated Hospitals

Image of trial facility.
Fred Hutch/University Of Washington Cancer Consortium
Image of trial facility.
University Of Washington

Clinical Trials Hannah Linden, MD is currently running

Image of trial facility.

Imaging and Abemaciclib

for Breast Cancer

This phase II trial tests the accuracy of functional imaging (FFNP)-positron emission tomography (PET)/computed tomography (CT) to predict response to abemaciclib plus endocrine therapy. Abemaciclib is a drug used to treat certain types of hormone receptor positive (HR+), HER2 negative breast cancer. Abemaciclib blocks certain proteins, which may help keep tumor cells from growing. Endocrine therapy adds, blocks, or removes hormones that can cause cancer to grow. FFNP PET imaging is a form of x-ray that uses FFNP as an imaging agent that may provide more precise information about the location of tumors that "light up" with FFNP than a PET scan alone can provide.
Recruiting1 award Phase 2

More about Hannah Linden, MD

Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Hannah Linden, MD has experience with
  • Abemaciclib
  • Enobosarm
  • F-18 16 Alpha-Fluoroestradiol
  • Fulvestrant
  • Palbociclib
  • ZW25 (Zanidatamab)
Breakdown of trials Hannah Linden, MD has run
Breast Cancer
Breast cancer
No change needed.
Thyroid Cancer

Other Doctors you might be interested in

Stephen SmithFred Hutch/University of Washington Cancer Consortium
Suman JayadevUniversity of Washington
Michael J Wagner, MDUniversity of Washington

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hannah Linden, MD specialize in?
Hannah Linden, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are Stage IV.
Is Hannah Linden, MD currently recruiting for clinical trials?
Yes, Hannah Linden, MD is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Hannah Linden, MD has studied deeply?
Yes, Hannah Linden, MD has studied treatments such as Abemaciclib, Enobosarm, F-18 16 Alpha-Fluoroestradiol.
What is the best way to schedule an appointment with Hannah Linden, MD?
Apply for one of the trials that Hannah Linden, MD is conducting.
What is the office address of Hannah Linden, MD?
The office of Hannah Linden, MD is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security